Acute lymphoblastic leukemia Doctors in test — Page 2

Trained at Duke University and Fred Hutchinson Cancer Research Center – Dr. Gulsan specializes in stem cell transplantation for acute lymphoblastic leukemia.

• Over 25 years of experience leading Gazi University's Adult Stem Cell Transplant Unit
• Published 60+ research papers on hematologic malignancies
• Head of Hematology Department at Gazi University (2008-2014)
• Member of the European Society for Blood and Marrow Transplantation

Dr. Litleaungdej is a hematology specialist trained at Thammasat University, focusing on blood disorders including acute lymphoblastic leukemia.

• Graduated with honors from Naresuan University's medical program
• Completed hematology fellowship at one of Thailand's top teaching hospitals
• Pioneered hematology services at Huahin Hospital as their first specialist
• Co-author of research on cancer-associated thrombosis risk prediction

Professor Hilmi Apak specializes in pediatric hematology and oncology, with a strong focus on acute lymphoblastic leukemia at Valued Med Hub Hospitals.

• Over 26 years of experience of experience in pediatric hematology and oncology
• Head of the Department of Internal Medical Sciences at Istanbul University-Cerrahpaşa
• Specialized in pediatric hematology and oncology since 2000
• Published research on molecular aspects of hematological disorders

Phd Viola Fox leads a certified interdisciplinary cancer center, specializing in cutting-edge treatments for Acute lymphoblastic leukemia.

• Expert in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with a focus on molecular diagnostics
• Active in molecular biology research for innovative treatments
• Member of German and American oncology societies

Prof. Hasan Atilla Ozkan brings 23 years of experience of hematology expertise, specializing in stem cell transplantation at VM Medical Park Pendik Hospital.

• Current president of the Turkish Therapeutic Apheresis Association
• Certified in autologous and allogeneic stem cell transplantation
• Awarded for research at the 6th Turkish Therapeutic Apheresis Congress
• Professor at Yeditepe University's Department of Internal Medicine
• Full member of the Turkish Hematology Association and EBMT

Professor Drach specializes in oncology with extensive experience at Vienna Medical University and directs the Josefstadt Private Clinic.

• Head physician at University Hospital of Internal Medicine I in Vienna
• Member of the Board of Directors of the Austrian Society of Hematology and Oncology
• Published over 120 scientific papers
• Continuing education in nutrition and cancer from University of Freiburg

Specializes in Medical Oncology with extensive training from Akdeniz University – Dr. Alemdar focuses on acute lymphoblastic leukemia.

• Board-certified in Medical Oncology
• Trained at Akdeniz University Hospital
• Years of experience in Internal Medicine and Oncology

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.